United States · FDA National Drug Code directory
Oracit
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46287-014_8691f6bc-18e9-4336-8e10-c702ecace00a
- Product NDC
- 46287-014
- Form
- SOLUTION
- Composition / generic term
- Citric Acid and Sodium Citrate
- Labeler
- CMP Pharma, Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 19840515
- Source listing expiry
- 20261231
Source-listed ingredients
- CITRIC ACID MONOHYDRATE — 640 mg/5mL
- TRISODIUM CITRATE DIHYDRATE — 490 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 500 mL in 1 BOTTLE (46287-014-01) · 46287-014-01
- 10 BOTTLE, UNIT-DOSE in 1 CARTON (46287-014-15) / 15 mL in 1 BOTTLE, UNIT-DOSE · 46287-014-15
- 10 BOTTLE, UNIT-DOSE in 1 CARTON (46287-014-30) / 30 mL in 1 BOTTLE, UNIT-DOSE · 46287-014-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →